Ackman: Pharma Is Prime to Benefit Shareholders

April 23 (Bloomberg) -- Bill Ackman, CEO at Pershing Square Capital and Michael Pearson, Chairman/CEO at Valeant Pharmaceuticals, discuss the value of the Valeant and Allergan deal to shareholders on Bloomberg Television’s “Market Makers.” (Source: Bloomberg)
Square Rival iZettle Raises $67M From Intel and Zouk
25:08 - Today’s "BWest Byte" is $67 million, for how much iZettle, a Swedish payments startup and rival to Jack Dorsey's Square, has raised from Intel and Zouk. Bloomberg's Matt Miller reports on "Bloomberg West." (Source: Bloomberg)
  • What's Next for Flexible Electronic Technology?
  • Facebook Cracks Down on Video Pirates
  • Deep Dive: Is Market Turmoil Hurting Consumer Sentiment?